Furthermore, our study aimed to determine the associations between plasma apoA-IV levels, sepsis-associated dyslipidaemia, causes of severe illness, severity of illness and survival in a large cohort of patients with systemic inflammatory response syndrome (SIRS)/sepsis. This evidence concerns the gene APOA4 and Sepsis.